Real-World Evidence generation becoming increasingly important but also very complicated Based on the EMA’s horizon scanning activities, it has been…
Archives
- October 2022 (1)
- July 2022 (1)
- June 2022 (1)
- May 2022 (2)
Categories
-
Recent Posts
- Real World Evidence, an opportunity to prove value of highly individualized medicines in real life clinical practice, but limitations need to be addressed.
- HTA and decision making in the reimbursement of medicines
- Changing the Pathway for successful Biopharma Launches
- How AI And Machine Learning Can Improve Patient Access To Orphan Drugs
- How Market Access Challenges Lead To Solidarity Conflicts
